Literature DB >> 33075389

Variation in Best Practice Measures in Patients With Severe Hospital-Acquired Acute Kidney Injury: A Multicenter Study.

Dennis G Moledina1, Olivia Belliveau1, Yu Yamamoto1, Tanima Arora1, Kyle A Carey2, Matthew Churpek3, Melissa Martin1, Caitlin M Partridge4, Sherry G Mansour1, Chirag R Parikh5, Jay L Koyner2, F Perry Wilson6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33075389      PMCID： PMC8672301          DOI： 10.1053/j.ajkd.2020.08.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  10 in total

1.  Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle.

Authors:  Karen Guerin; Julia Wagner; Keith Rains; Mary Bessesen
Journal:  Am J Infect Control       Date:  2010-06-08       Impact factor: 2.918

2.  A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children.

Authors:  Stuart L Goldstein; Devesh Dahale; Eric S Kirkendall; Theresa Mottes; Heather Kaplan; Stephen Muething; David J Askenazi; Traci Henderson; Lynn Dill; Michael J G Somers; Jessica Kerr; Jennifer Gilarde; Joshua Zaritsky; Valerie Bica; Patrick D Brophy; Jason Misurac; Richard Hackbarth; Julia Steinke; Joann Mooney; Sara Ogrin; Vimal Chadha; Bradley Warady; Richard Ogden; Wendy Hoebing; Jordan Symons; Karyn Yonekawa; Shina Menon; Lisa Abrams; Scott Sutherland; Patricia Weng; Fang Zhang; Kathleen Walsh
Journal:  Kidney Int       Date:  2019-11-01       Impact factor: 10.612

3.  A Multinational Observational Study Exploring Adherence With the Kidney Disease: Improving Global Outcomes Recommendations for Prevention of Acute Kidney Injury After Cardiac Surgery.

Authors:  Mira Küllmar; Raphael Weiß; Marlies Ostermann; Sara Campos; Neus Grau Novellas; Gary Thomson; Michael Haffner; Christian Arndt; Hinnerk Wulf; Marc Irqsusi; Fabrizio Monaco; Ambra Licia Di Prima; Mercedes García-Alvarez; Stefano Italiano; Mar Felipe Correoso; Gudrun Kunst; Shrijit Nair; Camilla L'Acqua; Eric Hoste; Wim Vandenberghe; Patrick M Honore; John A Kellum; Lui Forni; Philippe Grieshaber; Carola Wempe; Melanie Meersch; Alexander Zarbock
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

4.  Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.

Authors:  Chi-Yuan Hsu; Kathleen D Liu; Jingrong Yang; David V Glidden; Thida C Tan; Leonid Pravoverov; Sijie Zheng; Alan S Go
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 8.237

5.  World incidence of AKI: a meta-analysis.

Authors:  Paweena Susantitaphong; Dinna N Cruz; Jorge Cerda; Maher Abulfaraj; Fahad Alqahtani; Ioannis Koulouridis; Bertrand L Jaber
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

6.  Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units.

Authors:  S Finlay; B Bray; A J Lewington; C T Hunter-Rowe; A Banerjee; J M Atkinson; M C Jones
Journal:  Clin Med (Lond)       Date:  2013-06       Impact factor: 2.659

7.  Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.

Authors:  Steven G Coca; Amit X Garg; Madhav Swaminathan; Susan Garwood; Kwangik Hong; Heather Thiessen-Philbrook; Cary Passik; Jay L Koyner; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2013-09-29       Impact factor: 5.992

8.  Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.

Authors:  Melanie Meersch; Christoph Schmidt; Andreas Hoffmeier; Hugo Van Aken; Carola Wempe; Joachim Gerss; Alexander Zarbock
Journal:  Intensive Care Med       Date:  2017-01-21       Impact factor: 17.440

9.  Electronic Alerts for Acute Kidney Injury Amelioration (ELAIA-1): a completely electronic, multicentre, randomised controlled trial: design and rationale.

Authors:  Marina Mutter; Melissa Martin; Yu Yamamoto; Aditya Biswas; Boian Etropolski; Harold Feldman; Amit Garg; Noah Gourlie; Stephen Latham; Haiqun Lin; Paul M Palevsky; Chirag Parikh; Erica Moreira; Ugochukwu Ugwuowo; Francis P Wilson
Journal:  BMJ Open       Date:  2019-06-01       Impact factor: 2.692

Review 10.  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).

Authors:  John A Kellum; Norbert Lameire
Journal:  Crit Care       Date:  2013-02-04       Impact factor: 9.097
  10 in total
  5 in total

Review 1.  Optimizing the Design and Analysis of Future AKI Trials.

Authors:  Matthieu Legrand; Sean M Bagshaw; Jay L Koyner; Ivonne H Schulman; Michael R Mathis; Juliane Bernholz; Steven Coca; Martin Gallagher; Stéphane Gaudry; Kathleen D Liu; Ravindra L Mehta; Romain Pirracchio; Abigail Ryan; Dominik Steubl; Norman Stockbridge; Fredrik Erlandsson; Alparslan Turan; F Perry Wilson; Alexander Zarbock; Michael P Bokoch; Jonathan D Casey; Patrick Rossignol; Michael O Harhay
Journal:  J Am Soc Nephrol       Date:  2022-07-13       Impact factor: 14.978

2.  Performance of a Standardized Clinical Assay for Urinary C-C Motif Chemokine Ligand 14 (CCL14) for Persistent Severe Acute Kidney Injury.

Authors:  Jay L Koyner; Lakhmir S Chawla; Azra Bihorac; Kyle J Gunnerson; Rebecca Schroeder; Sevag Demirjian; Luke Hodgson; Jennifer A Frey; Scott T Wilber; J Patrick Kampf; Thomas Kwan; Paul McPherson; John A Kellum
Journal:  Kidney360       Date:  2022-03-24

3.  Towards a Better Crystal Ball: Urinary C-C Motif Chemokine Ligand 14 (CCL14) and Persistent Severe AKI.

Authors:  Justin M Belcher
Journal:  Kidney360       Date:  2022-07-28

Review 4.  COVID-19 Survival and its impact on chronic kidney disease.

Authors:  Joshua D Long; Ian Strohbehn; Rani Sawtell; Roby Bhattacharyya; Meghan E Sise
Journal:  Transl Res       Date:  2021-11-10       Impact factor: 7.012

5.  Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.

Authors:  Megan L Baker; Yu Yamamoto; Mark A Perazella; Nazli Dizman; Anushree C Shirali; Navid Hafez; Jason Weinstein; Michael Simonov; Jeffrey M Testani; Harriet M Kluger; Lloyd G Cantley; Chirag R Parikh; F Perry Wilson; Dennis G Moledina
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.